Akash Mishra

Akash Mishra

Director Director DIN 08249325
DIN 08249325 First appointment Oct 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value Locked Premium profile

About Akash Mishra

Data last updated:

Akash Mishra has 8 years in corporate governance. Formerly with 1 company, such as Apionex Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08249325
Primary Designation Director
First Appointment 05 Oct 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Apionex Pharma Private Limited U33209MH2018PTC315329
Director05 Oct 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apionex Pharma Private Limited
Premium access

Shareholding and investment profile for Akash Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Mishra

Akash Mishra has 8 years in corporate governance. Formerly with 1 company, such as Apionex Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Akash Mishra is associated with 0 companies as a director.

Akash Mishra has expertise in General Business.

Akash Mishra has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available